02.27.24 -- Take Your Small Molecule Drug Development To The Next Level

Our scientific team at LAXAI is committed to overcoming solubility, in vivo exposure, solid form, and stability challenges to help develop complex therapeutic compounds from preclinical and clinical to market, tailored to your unique requirements.

Pfizer CentreOne’s right first time approach accelerates your project through key milestones with a robust technology transfer process that ensures a fast start and process analytical technology that helps increase efficiency and reduce cost.

At Kymanox, our science-centric CMC team has global experience in strategic planning and authoring regulatory submissions for the pharmaceutical, biologic, and combination product industries.

The Uhlmann BEC 300 is a single-lane unit integrates blistering, cartoning, and serialization, in response to the continued increase in demand for blister, a preferred packaging format when the need for security, stability, and sustained efficacy is significant.

Our extensive formulation know-how, coupled with our agile and flexible approach to clinical and commercial manufacturing, makes us the ideal partner to provide an end-to-end solution for the development of MR drug products.

Finding a strategic CDMO that will offer tailored solutions for your late phase clinical and commercial needs, mitigate risks, and bolster your supply chain is crucial for meeting project milestones.

Nanoform is an innovative nanoparticle medicine enabling company that supplies best-in-class nanoforming™ services to the pharmaceutical industry.

With world-class facilities, the state-of-the-art equipment and some of the industry’s most talented people, INCOG has been purpose-built to provide better solutions for the global injectable drug product sector.

Early identification of potential absorption risks is critical for rapid and efficient drug development. Lonza's PBPK modeling services are designed to de-risk your drug development program.

PCI Pharma Services has invested in state-of-the-art containment equipment and created a ‘Potent Passport’ philosophy to identify the specific handling requirements for any HPAPI project.